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Patient history and treatment
In 1995, a 12 year old patient presented with recurrent fever, diffuse lymphadenopathy, splenomegaly and was found to be bacteremic with S. Enteritidis. The patient was diagnosed with IL-12 beta-1 receptor deficiency (homozygous mutation deficiency of the IL-12 beta 1 chain) and was started on Interferon γ (IFNγ) treatment and remained on this until the age of 13. At the age of 16 the patient was diagnosed with purulent pericarditis, secondary to S. Enteritidis, and IFNγ treatment was restarted. Between the ages of 16 and 21 (1999-2004) , the patient was bacteremic with a S. Enteritidis-like organism on multiple occasions and was treated with various antibiotics, including Ciprofloxacin, Azithromycin and Ceftriaxone. Every bacteremia episode was characterized by recurrence of vasculitic rash, arthritis and malaise that the patient described was becoming less severe with time. Initially, the vasculitic rash was widespread, involving his face, and later it started becoming limited to smaller and smaller areas until it finally completely disappeared during the last episodes. At the age of 21 an elective laparoscopic cholecystectomy was performed but no evidence of cholecystitis was identified on tissue pathology. Between the ages of 21 and 29 (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) , the patient continued to have multiple bacteremia episodes, sometimes accompanied by a macular rash on trunk as well as progressive hypergammaglobulinemia. Numerous investigations including an FDG-PET, total body CT scans and MRIs, bone scans, bone marrow biopsies and echocardiograms failed to localize a tissue where Salmonella was resident. The patient also developed progressive normocytic normochromic anemia as well as chronic weight loss and Creactive protein elevation. Importantly, Salmonella could not be cultured from the stool and there was no evidence of transmission as fecal screens of close relatives were negative. Typing of the isolates yielded inconclusive results leading to their classification as atypical S. Enteritidis.
Genetic determination of antimicrobial resistance in patient isolates
We determined if sequence polymorphisms that could be responsible for the increased resistance to the antimicrobials Ciprofloxacin and Azithromycin were present in the patient isolates. At least one of three substitutions previously associated with quinolone resistance, Asp87Gly and Ser83Phe in gyrA and Ser464Phe in gyrB 1 , were present in each of the isolates (Extended Data Table I ). No known genetic changes associated with macrolide resistance were identified in the patient isolates.
Classes of pseudogenes in patient isolates
Several anaerobic metabolism pathways have multiple disrupted genes in the patient isolates that could affect their ability to survive in the gut 2, 3 . Two genes of the nitrate utilization pathway, narK and narX, are pseudogenes in the patient isolates. Salmonella have evolved to use tetrathionate, a byproduct of gut inflammation, as an additional terminal electron acceptor that allows Salmonella to outcompete with the patient isolates had a crenulated morphology revealed by transmission electron microscopy (Supplementary Information Figure 7B ). Furthermore, ten of the eleven patient isolates lacked a functional rfaL (waaL) encoding the O-antigen ligase that links the O-polysaccharide to the completed core of LPS (Supplementary Information  Table II ). Consistently, patient isolates produced LPS lacking O-antigen (Supplementary Information Figure 7A ) that is consistent with the extreme sensitivity to normal human serum and low amounts of complement (Supplementary Information Figure 8 ).
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